Prostacyclin and thromboxane in benign and malignant breast tumours (Q36027781)

11 August 2017

Prostacyclin and thromboxane in benign and malignant breast tumours (English)

1 reference

11 August 2017

Laekeman GM

1

1 reference

11 August 2017

Vergote IB

2

1 reference

11 August 2017

Keersmaekers GM

3

1 reference

11 August 2017

Heiremans J

4

1 reference

11 August 2017

Haensch CF

5

1 reference

11 August 2017

de Roy G

6

1 reference

11 August 2017

Uyttenbroeck FL

7

1 reference

11 August 2017

Herman AG

8

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 September 1986

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

54

1 reference

11 August 2017

3

1 reference

11 August 2017

431-437

1 reference

Prostaglandins in breast cancer: relationship to disease stage and hormone status

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001625

The prostacyclin--thromboxane A2 balance: pathophysiological and therapeutic implications

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001625

Platelet—tumor-cell interactions in mice. The role of platelets in the spread of malignant disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001625

Prostaglandin F2 alpha in benign and malignant breast tumours

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001625

Prostacyclin and thromboxane in breast cancer: relationship between steroid receptor status and medroxyprogesterone acetate

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001625

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001625

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001625

Prostaglandin synthetase and prostaglandin e2 levels in human breast carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001625

Breast cancer, prostaglandins, and bone metastases

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001625

Increasing the efficiency of cancer chemotherapy with heparin: "clinical study".

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001625

Radioimmunoassay of prostaglandins and thromboxanes.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001625

Pharmacological control of prostaglandin and thromboxane release from macrophages

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001625

Prostaglandin in human breast cancer: Evidence suggesting that an elevated prostaglandin production is a marker of high metastatic potential for neoplastic cells.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2001625

Macrophages synthesise and release prostaglandins in response to inflammatory stimuli

23 September 2018

1 reference

12 December 2020

The inhibitory effect of heparin and warfarin treatments on the intravascular survival of B16 melanoma cells in syngeneic C57 mice

1 reference

12 December 2020

Prostaglandins as mediators of bone resorption in renal and breast tumours

1 reference

12 December 2020

On the occurrence of prostacyclin metabolites in plasma and vascular tissue as determined radioimmunologically

1 reference

12 December 2020

Lysosomal cathepsin B: correlation with metastatic potential

1 reference

12 December 2020

Prostacyclin: a potent antimetastatic agent

1 reference

12 December 2020

Prostaglandin E2 and cyclic AMP in tumor and plasma of breast cancer patients

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1986.194

1 reference

11 August 2017

1 reference

11 August 2017

PubMed publication ID

3530307

1 reference